U.S. Markets for Drug and Fluid Delivery Devices, December 2015

Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.  To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014.  In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumulative pharmaceutical sales and representing nearly 13% of the nation’s total healthcare spending.  This report covers injection/infusion, transdermal, and inhalation drug delivery devices.  

This new report by Medtech Insight presents a detailed overview of the U.S. drug and fluid delivery devices market.  Major topics covered by this report include an overview of drug delivery technologies, injection/infusion drug delivery systems (e.g., syringes, injection pens, needleless jet injectors, infusion pumps and disposables, gravity infusion systems, and vascular access devices), transdermal drug delivery systems (e.g., patch-based pharmaceutical products for cardiovascular disease management, central nervous system disorder management, hormone replacement therapy, acute and chronic pain management, and urologic disorder management), and inhalation drug delivery systems (e.g., inhaled insulin delivery systems and inhaled respiratory drug systems such as dry powder inhaler- and metered dose inhaler-based preparations for the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis).